These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prescription-drug prices. Frank RG N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294 [No Abstract] [Full Text] [Related]
6. Will lower drug prices jeopardize drug research? A policy fact sheet. Light DW; Lexchin J Am J Bioeth; 2004; 4(1):W1-4. PubMed ID: 15035915 [No Abstract] [Full Text] [Related]
7. PhRMA sues on 340B orphans. Lee J Mod Healthc; 2013 Oct; 43(40):17. PubMed ID: 24340726 [No Abstract] [Full Text] [Related]
8. The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs. Mello MM; Studdert DM; Brennan TA N Engl J Med; 2004 Feb; 350(6):608-13. PubMed ID: 14762190 [No Abstract] [Full Text] [Related]
9. Opinion: price controls on prescription drugs. Franks B N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791 [No Abstract] [Full Text] [Related]
10. Can price and regulatory controls replace free market competition in the drug industry? Buc NL; Levitt GM Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839 [No Abstract] [Full Text] [Related]
11. Pricing pain: relief in sight on drug costs? J Am Health Policy; 1992; 2(6):28-31. PubMed ID: 10122415 [TBL] [Abstract][Full Text] [Related]
12. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs. Gudiksen KL; King JS J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534 [No Abstract] [Full Text] [Related]
13. The pharmaceutical industry--prices and progress. Scherer FM N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432 [No Abstract] [Full Text] [Related]
14. The pharmaceutical industry--to whom is it accountable? Holmer AF N Engl J Med; 2000 Nov; 343(19):1415; discussion 1417. PubMed ID: 11183877 [No Abstract] [Full Text] [Related]
15. When will the U.S. flinch at cancer drug prices? Vanchieri C J Natl Cancer Inst; 2005 May; 97(9):624-6. PubMed ID: 15870428 [No Abstract] [Full Text] [Related]
16. Meeting resistance. Express Scripts-Medco deal called anti-competitive. Lee J Mod Healthc; 2011 Aug; 41(32):10-1. PubMed ID: 21879692 [No Abstract] [Full Text] [Related]
17. Rx: Canadian drugs. Bugden S N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15014193 [No Abstract] [Full Text] [Related]
18. New rules for US drug reimbursement. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382 [No Abstract] [Full Text] [Related]
19. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states. Latham SR J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406 [No Abstract] [Full Text] [Related]